StockSelector.com
  Research, Select, & Monitor Wednesday, August 16, 2017 7:25:27 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amdocs, Ltd.$63.26$.40.64%

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Amdocs Limited Reports Record Quarterly Revenue of $941M
   Tuesday, November 08, 2016 4:01:29 PM ET

Expects Fiscal 2017 Revenue Growth of 2.0-6.0% YoY

Quarterly Cash Dividend to be Raised From $0.195 to $0.22 Per Share, Subject to Shareholder Approval at the January 2017 Annual Meeting

Key highlights:

-- Fourth fiscal quarter revenue of $941 million, at the midpoint of the $920-$960 million guidance range. As we anticipated, foreign currency movements negatively affected revenue by approximately $2 million relative to the third quarter of fiscal 2016

-- Diluted GAAP EPS of $0.64 for the fourth fiscal quarter, below the $0.66-$0.74 guidance range due to higher acquisition-related costs in connection with the acquisitions of Pontis, Vindicia and Brite:Bill announced on September 14, 2016

-- Fourth fiscal quarter diluted non-GAAP EPS of $0.89, slightly above the mid-point of the $0.85-$0.91 guidance range (non-GAAP EPS excludes amortization of purchased intangible assets and other acquisition-related costs, and equity-based compensation expense, net of related tax effects)

-- Fourth fiscal quarter GAAP operating income of $118 million; non-GAAP operating income of $161 million; non-GAAP operating margin of 17.1%

-- Free cash flow of $125 million for the fourth fiscal quarter

-- Repurchased $90 million of ordinary shares during the fourth fiscal quarter

-- Twelve-month backlog of $3.17 billion at the end of the fourth fiscal quarter, up $60 million from the end of the third quarter of fiscal 2016

-- The board of directors approved a $0.195 per share quarterly cash dividend to be paid on January 13, 2017, and, subject to shareholders’ approval at the January 2017 annual general meeting of shareholders, an increase in the quarterly cash dividend to $0.22 per share, anticipated to be paid in April 2017

-- First quarter fiscal 2017 guidance: Expected revenue of approximately $935-$975 million. Expected diluted GAAP EPS of approximately $0.59-$0.67. Expected diluted non-GAAP EPS of approximately $0.87-$0.93 (which excludes amortization of purchased intangible assets and other acquisition-related costs and approximately $0.09-$0.10 per share of equity-based compensation expense, net of related tax effects)

-- Full year fiscal 2017 guidance: Expected revenue growth of 2.0-6.0% on a constant currency basis and reported basis. Expected non-GAAP diluted earnings per share growth of roughly 4.5-8.5%, incorporating the impact of anticipated share repurchase activity over the course of the fiscal year

Amdocs Limited (DOX ) today reported that for its fourth fiscal quarter ended September 30, 2016, revenue was $940.7 million, up 1.1% or $10.5 million sequentially from the third fiscal quarter of 2016 and up 1.5% as compared to last year’s fourth fiscal quarter. Revenue for the fourth fiscal quarter of 2016 includes a negative impact from foreign currency movements of approximately $2 million relative to the third quarter of fiscal 2016. The Company’s GAAP net income for the fourth quarter of fiscal 2016 was $95.7 million, or $0.64 per diluted share, compared to GAAP net income of $91.1 million, or $0.59 per diluted share, in the prior fiscal year’s fourth quarter. Net income on a non-GAAP basis was $132.4 million, or $0.89 per diluted share, compared to non-GAAP net income of $130.4 million, or $0.84 per diluted share, in the fourth quarter of fiscal 2015. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs and equity-based compensation expenses of $36.7 million, net of related tax effects, in the fourth quarter of fiscal 2016, and excludes such amortization and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets and equity-based compensation expenses of $39.2 million, net of related tax effects, in the fourth quarter of fiscal 2015.

"Our fourth quarter performance was solid and culminated in a stronger second half along the lines we predicted a year ago. North America showed further signs of stabilization, while Europe and Rest of World delivered strong double-digit growth for the full year notwithstanding normal fluctuations in customer activity in Q4. Late in the quarter, we expanded our digital capabilities with the combined acquisitions of Pontis, Brite:Bill and Vindicia for roughly $260 million in cash. We also delivered on our plan to return 100% of free cash flow to shareholders in the second half of the fiscal year, consistent with our ongoing commitment to the disciplined and proactive allocation of cash," said Eli Gelman, president and chief executive officer of Amdocs Management Limited.

Gelman continued, "During the fourth quarter we expanded our activities with several important customers. In Latin America, Telefonica selected the Amdocs Data Hub as the next logical step in the quad-play transformation project we are supporting at its Vivo operations in Brazil. The Amdocs solution extracts and analyzes large volumes of customer data from a wide range of operational platforms and will give Telefonica Brazil the business insights needed to react quickly to changing market dynamics. In the Philippines, Globe Telecom selected Amdocs Revenue Guard for automated, analytics-driven revenue assurance, a service that builds on the market-leading technology we secured through our acquisition of cVidya in January 2016."

Gelman concluded, "We enter fiscal 2017 focused on building the engines to support our customers in strategic areas such as digital modernization, the enterprise segment, Pay TV and network function virtualization. With the visibility provided by our record 12-month backlog we are targeting full year non-GAAP earnings per share growth of 4.5% to 8.5% while monitoring various macro and industry specific risks, including the impact of consolidation activity in North America. Finally, we are pleased to announce a planned increase in the quarterly cash dividend of nearly 13% to 22 cents per share, payable in April 2017 if approved by shareholders at the annual meeting in January 2017. This marks the fourth consecutive year that our Board has approved an increase in the dividend and further demonstrates our confidence in the future success of Amdocs."

Financial Discussion of Fourth Fiscal Quarter Results

Free cash flow was $125 million for the fourth quarter of fiscal 2016, comprised of cash flow from operations of $153 million, less $28 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.17 billion at the end of the fourth quarter of fiscal 2016, up $60 million from the end of the prior quarter, with approximately half of the increase due to acquisitions.

Fiscal Year 2016 Results

For the fiscal year ended September 30, 2016, revenue increased by 2.0% to $3.7 billion. The Company’s GAAP net income in fiscal 2016 was $409.3 million, or $2.71 per diluted share, compared to GAAP net income of $446.2 million, or $2.85 per diluted share, in fiscal 2015. Fiscal 2016 net income on a non-GAAP basis was $540.1 million, or $3.57 per diluted share (excluding amortization of purchased intangible assets and other acquisition-related costs and equity-based compensation expenses of $130.8 million, net of related tax effects), compared to non-GAAP net income of $529.7 million, or $3.38 per diluted share, in fiscal 2015 (excluding amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, changes in fair value of certain acquisition-related liabilities and equity-based compensation expenses of $83.5 million, net of related tax effects).

Financial Outlook

Amdocs expects that revenue for the first quarter of fiscal 2017 will be approximately $935-$975 million. Embedded within this guidance is an immaterial sequential impact from foreign currency fluctuations as compared to the fourth quarter of fiscal 2016. This outlook takes into consideration the company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, Amdocs notes that it cannot predict all possible outcomes, including those resulting from AT&T’s proposed merger with Time Warner or from other current and potential customer consolidation activity in North America.

Amdocs estimates GAAP diluted earnings per share for the first fiscal quarter of 2017 will be $0.59-$0.67. Diluted earnings per share on a non-GAAP basis for the first quarter of fiscal 2017 is expected to be $0.87-$0.93, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.09-$0.10 per share of equity-based compensation expense, net of related tax effects.

Quarterly Cash Dividend Program

On November 8, 2016, the Board approved the Company’s next quarterly cash dividend payment of $0.195 per share and set December 30, 2016 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 13, 2017. The Board also approved an increase in the Company’s quarterly cash dividend payment to $0.22 per share, which is anticipated to be paid in April 2017, provided that the increase is approved by shareholders at the January 2017 annual general meeting of shareholders.

Conference Call Details

Amdocs will host a conference call on November 8, 2016 at 5:00 p.m. Eastern Time to discuss the Company’s fourth fiscal quarter and fiscal year 2016 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 97721633. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Amdocs Analyst & Investor Briefing

Amdocs will host an Analyst and Investor briefing on Wednesday, December 14 at the NASDAQ market site headquarters in New York City’s midtown. Please contact investor relations for further details and check our investor relations website several days in advance for details on how to access the live webcast.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

-- amortization of purchased intangible assets and other acquisition-related costs;

-- changes in fair value of certain acquisition-related liabilities;

-- nonrecurring restructuring charges associated with the Comverse acquisition;

-- equity-based compensation expense; and

-- tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

About Amdocs

Amdocs is the market leader in customer experience software solutions and services for the world’s largest communications, entertainment and media service providers. For more than 30 years, Amdocs solutions, which include BSS, OSS, network control, optimization and network functions virtualization, coupled with professional and managed services, have accelerated business value for its customers by simplifying business complexity, reducing costs and delivering a world-class customer experience.

The Amdocs portfolio enables service providers to capture the world of digital immediacy by operating across digital dimensions to engage customers with personalized, omni-channel experiences; creating a diversified business to capture new revenue streams; becoming data empowered to make business and operational decisions based on insight-based and predictive analytics; and achieving service agility to accelerate the fast rollout of new technologies and hybrid network services.

Amdocs and its 25,000 employees serve customers in over 90 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $3.7 billion in fiscal 2016.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2015 filed on December 10, 2015 and our Form 6-K furnished for the first quarter of fiscal 2016 on February 16, 2016, for the second quarter of fiscal 2016 on May 17, 2016 and for the third quarter of fiscal 2016 on August 8, 2016.

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                                                       Three months ended          Fiscal year ended
                                                       September 30,               September 30,
                                                          2016         2015           2016           2015
Revenue                                                $  940,656   $  926,776     $  3,718,229   $  3,643,538
Operating expenses:
Cost of revenue                                           611,107      603,105        2,408,040      2,349,488
Research and development                                  61,043       65,900         252,292        254,944
Selling, general and administrative                       117,030      111,191        464,883        440,085
Amortization of purchased intangible assets and other     32,979       23,880         109,873        70,073
Restructuring charges                                     -            13,000         -              13,000
                                                          822,159      817,076        3,235,088      3,127,590
Operating income                                          118,497      109,700        483,141        515,948
Interest and other income (expense), net                  649          (1,375  )      1,557          (2,544    )
Income before income taxes                                119,146      108,325        484,698        513,404
Income taxes                                              23,437       17,195         75,367         67,241
Net income                                             $  95,709    $  91,130      $  409,331     $  446,163
Basic earnings per share                               $  0.65      $  0.60        $  2.74        $  2.89
Diluted earnings per share                             $  0.64      $  0.59        $  2.71        $  2.85
Basic weighted average number of shares outstanding       147,281      152,601        149,168        154,423
Diluted weighted average number of shares outstanding     148,984      155,201        151,176        156,809
Cash dividends declared per share                      $  0.195     $  0.170       $  0.755       $  0.665
AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                                                       Three months ended        Fiscal year ended
                                                       September 30,             September 30,
                                                          2016         2015         2016           2015
Revenue                                                $  940,656   $  926,776   $  3,718,229   $  3,643,538
Non-GAAP operating income                                 161,078      156,917      635,714        618,675
Non-GAAP net income                                       132,360      130,353      540,116        529,700
Non-GAAP diluted earnings per share                    $  0.89      $  0.84      $  3.57        $  3.38
Diluted weighted average number of shares outstanding     148,984      155,201      151,176        156,809
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                         Three months ended
                         September 30, 2016
                                     Reconciliation items
                         GAAP        Amortization of     Equity based   Tax effect   Non-GAAP
                                     purchased           compensation
                                     intangible assets   expense
                                     and other
Operating expenses:
Cost of revenue          $  611,107  $    -              $   (4,802 )   $  -         $  606,305
Research and                61,043        -                  (929   )      -            60,114
development
Selling, general and        117,030       -                  (3,871 )      -            113,159
administrative
Amortization of             32,979        (32,979 )          -             -            -
purchased intangible
assets and other
Total operating expenses    822,159       (32,979 )          (9,602 )      -            779,578
Operating income            118,497       32,979             9,602         -            161,078
Income taxes                23,437        -                  -             5,930        29,367
Net income               $  95,709   $    32,979         $   9,602      $  (5,930 )  $  132,360
                         Three months ended
                         September 30, 2015
                                    Reconciliation items
                         GAAP       Amortization of Equity based      Restructuring     Tax effect     Non-GAAP
                                    purchased       compensation      charges
                                    intangible      expense
                                    assets and other
Operating expenses:
Cost of revenue          $ 603,105  $     -         $    (3,854  )    $    -            $   -          $  599,251
Research and               65,900         -              (830    )         -                -             65,070
development
Selling, general and       111,191        -              (5,653  )         -                -             105,538
administrative
Amortization of            23,880         (23,880 )      -                 -                -             -
purchased intangible
assets and other
Restructuring charges      13,000         -              -                 (13,000 )        -             -
Total operating expenses   817,076        (23,880 )      (10,337 )         (13,000 )        -             769,859
Operating income           109,700        23,880         10,337            13,000           -             156,917
Income taxes               17,195         -              -                 -                7,994         25,189
Net income               $ 91,130   $     23,880    $    10,337       $    13,000       $   (7,994 )   $  130,353
 AMDOCS LIMITED
 Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
 (in thousands)
                          Fiscal year ended
                          September 30, 2016
                                        Reconciliation items
                          GAAP          Amortization of      Equity based         Tax effect   Non-GAAP
                                        purchased            compensation expense
                                        intangible assets
                                        and other
 Operating expenses:
 Cost of revenue          $  2,408,040  $   -                $  (18,249)          $  -         $  2,389,791
 Research and                252,292        -                   (3,742 )             -            248,550
 development
 Selling, general and        464,883        -                   (20,709)             -            444,174
 administrative
 Amortization of             109,873        (109,873 )          -                    -            -
 purchased intangible
 assets and other
 Total operating expenses    3,235,088      (109,873 )          (42,700)             -            3,082,515
 Operating income            483,141        109,873             42,700               -            635,714
 Income taxes                75,367         -                   -                    21,788       97,155
 Net income               $  409,331    $   109,873          $  42,700            $  (21,788)  $  540,116
                      Fiscal year ended
                      September 30, 2015
                                   Reconciliation items
                      GAAP         Amortization of     Equity based   Restructuring    Changes in fair     Tax effect      Non-GAAP
                                   purchased           compensation   charges          value of certain
                                   intangible assets   expense                         acquisition-
                                   and other                                           related liabilities
Operating expenses:
Cost of revenue       $ 2,349,488  $        -          $    (15,621 ) $      -         $      24,906       $   -           $  2,358,773
Research and            254,944             -               (3,400  )        -                -                -              251,544
development
Selling, general and    440,085             -               (25,539 )        -                -                -              414,546
administrative
Amortization of         70,073              (70,073  )      -                -                -                -              -
purchased
intangible assets
and other
Restructuring charges   13,000              -               -                (13,000 )        -                -              -
Total operating         3,127,590           (70,073  )      (44,560 )        (13,000 )        24,906           -              3,024,863
expenses
Operating income        515,948             70,073          44,560           13,000           (24,906 )        -              618,675
Interest and other      2,544               -               -                -                3,921            -              6,465
expense, net
Income taxes            67,241              -               -                -                -                15,269         82,510
Net income            $ 446,163    $        70,073     $    44,560    $      13,000    $      (28,827 )    $   (15,269 )   $  529,700
AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                                                                                    As of
                                                                                    September 30,    September 30,
                                                                                    2016             2015
ASSETS
Current assets
Cash, cash equivalents and short-term interest-bearing investments                  $    1,095,723   $    1,354,012
Accounts receivable, net, including unbilled of $134,122 and $80,197, respectively       818,531          714,784
Deferred income taxes                                                                    -                150,733
Prepaid expenses and other current assets                                                186,137          158,633
Total current assets                                                                     2,100,391        2,378,162
Equipment and leasehold improvements, net                                                331,728          309,320
Goodwill and other intangible assets, net                                                2,493,166        2,301,610
Other noncurrent assets                                                                  406,070          335,560
Total assets                                                                        $    5,331,355   $    5,324,652
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable, accruals and other                                                $    992,679     $    945,033
Short-term financing arrangements                                                        200,000          220,000
Deferred revenue                                                                         173,331          198,470
Total current liabilities                                                                1,366,010        1,363,503
Other noncurrent liabilities                                                             511,784          554,307
Shareholders’ equity                                                                     3,453,561        3,406,842
Total liabilities and shareholders’ equity                                          $    5,331,355   $    5,324,652

____________

Due to the early adoption of Accounting Standard Update 2015-17, starting the first quarter of fiscal year 2016, all deferred tax assets and liabilities are classified as noncurrent on the balance sheet. Prior balance sheets were not retrospectively adjusted.

AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
                                                                            Fiscal year ended September 30,
                                                                                 2016                 2015
Cash Flow from Operating Activities:
Net income                                                                  $    409,331         $    446,163
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization                                                    211,791              174,795
Equity-based compensation expense                                                42,700               44,560
Deferred income taxes                                                            (2,315    )          (26,887   )
Excess tax benefit from equity-based compensation                                (6,913    )          (5,949    )
Loss from short-term interest-bearing investments                                407                  476
Net changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable                                                              (70,859   )          39,829
Prepaid expenses and other current assets                                        (11,164   )          22,690
Other noncurrent assets                                                          2,587                7,406
Accounts payable, accrued expenses and accrued personnel                         59,982               63,894
Deferred revenue                                                                 (49,828   )          2,434
Income taxes payable                                                             10,112               23,474
Other noncurrent liabilities                                                     24,403               (20,263   )
Net cash provided by operating activities                                        620,234              772,622
Cash Flow from Investing Activities:
Payments for purchase of equipment and leasehold improvements, net               (130,086  )          (120,503  )
Proceeds from sale of short-term interest-bearing investments                    361,960              252,818
Purchase of short-term interest-bearing investments                              (370,742  )          (250,184  )
Net cash paid for acquisitions                                                   (283,450  )          (263,193  )
Other                                                                            (18,533   )          1,408
Net cash used in investing activities                                            (440,851  )          (379,654  )
Cash Flow from Financing Activities:
Borrowings under financing arrangements                                          200,000              220,000
Payments under financing arrangements                                            (220,000  )          (210,000  )
Repurchase of shares                                                             (413,422  )          (454,020  )
Proceeds from employee stock options exercised                                   89,600               78,206
Payments of dividends                                                            (109,304  )          (100,790  )
Excess tax benefit from equity-based compensation                                6,913                5,949
Other                                                                            (83       )          (9        )
Net cash used in financing activities                                            (446,296  )          (460,664  )
Net decrease in cash and cash equivalents                                        (266,913  )          (67,696   )
Cash and cash equivalents at beginning of period                                 1,035,573            1,103,269
Cash and cash equivalents at end of period                                  $    768,660         $    1,035,573
AMDOCS LIMITED
Supplementary Information
(in millions)
                   Three months ended
                   September 30,  June 30,   March 31,   December 31, September 30,
                   2016           2016       2016        2015         2015
North America      $    626.2     $  591.8   $   586.4   $    576.7   $    626.6
Europe                  118.9        126.3       139.2        128.9        115.3
Rest of the World       195.6        212.0       200.3        215.9        184.9
Total Revenue      $    940.7     $  930.1   $   925.9   $    921.5   $    926.8
                  Three months ended
                  September 30,  June 30,   March 31,   December 31, September 30,
                  2016           2016       2016        2015         2015
Managed Services  $    478.5     $  479.2   $   501.1   $    487.6   $    466.6
Revenue
                     Three months ended
                     September 30,  June 30,   March 31,   December 31, September 30,
                     2016           2016       2016        2015         2015
Customer Experience       924.9        908.1       902.3        894.4        899.4
Systems
Directory                 15.8         22.0        23.6         27.1         27.4
Total Revenue        $    940.7     $  930.1   $   925.9   $    921.5   $    926.8
                  As of
                  September 30,  June 30,   March 31,   December 31, September 30,
                  2016           2016       2016        2015         2015
12-Month Backlog  $    3,170     $  3,110   $   3,100   $    3,090   $    3,080
Contact:
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com

https://resource.globenewswire.com/Resource/Download/a1999944-c37c-44bf-85f9-58c986ca0965?size=1

<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzY2MDMyOTY=" alt="" width="1" height="1"/>



Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.